You have 9 free searches left this month | to do more

infigratinib

Infigratinib is a drug used to treat Breast Cancer, Achondroplasia, Advanced Malignant Solid Neoplasm, and other conditions. Infigratinib is being actively studied in 10 studies; no studies for this drug have been completed so far.

Top SponsorsTop SitesTop Investigators
QED Therapeutics, Inc.Stanford UniversityGuru P. Sonpavde
Stanford UniversityA.O.U.C. Polclinico di Bari U.O. Oncologia Medica UniversitariaNader Sanai
Guru P. SonpavdeAOU San Luigi GonzagaSameek Roychowdhury
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
Q
Recruiting
  • Achondroplasia
  • Infigratinib
  • Parkville, Victoria, Australia
  • +3 more
2022-04-05
Apr 5, 2022
S
Recruiting
  • Advanced Malignant Solid Neoplasm
  • +3 more
  • Infigratinib
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2022-02-15
Feb 15, 2022
N
Recruiting
  • Glioma
  • +2 more
  • Infigratinib
  • Chandler, Arizona
  • +2 more
2022-03-10
Mar 10, 2022
S
Recruiting
  • Breast Cancer
  • +3 more
  • Infigratinib
  • +3 more
  • Stanford, California
    Stanford University
2022-02-16
Feb 16, 2022
H
Not yet recruiting
  • Advanced Solid Tumor
  • +2 more
  • Infigratinib
  • Palo Alto, California
  • +9 more
2022-02-01
Feb 1, 2022
L
Recruiting
  • Gastric Cancer
  • +2 more
  • Infigratinib
  • Beijing, Beijing, China
  • +16 more
2021-08-19
Aug 19, 2021
M
Recruiting
  • Renal Pelvis and Ureter Urothelial Carcinoma
  • Infigratinib
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
2020-10-21
Oct 21, 2020
G
Recruiting
  • Bladder Transitional Cell Carcinoma
  • +2 more
  • Infigratinib
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2022-03-28
Mar 28, 2022
S
Not yet recruiting
  • Breast Cancer
  • +2 more
  • Stanford, California
    Stanford University
2022-01-20
Jan 20, 2022
Q
Recruiting
  • Upper Tract Urothelial Carcinomas
  • Urothelial Bladder Cancer
  • Infigratinib
  • Placebo
  • Tucson, Arizona
  • +132 more
2022-04-06
Apr 6, 2022